StockData
Traws Pharma, Inc. logo

Traws Pharma, Inc. (TRAW) stock

TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.24+0.01 (+3.94%)

Close on Nov 18, 2026Market cap $3.73MP/E –Yield –

Traws Pharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Traws Pharma's price to sales ratio was 4.6× on Apr 30, 2026, against 23.4× a year earlier. Over the last 5 years it ranged from 2.8× to 465.3×, with a median of 69.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 20264.6×+1.8
2025Dec 31, 20252.8×−116.0
2024Dec 31, 2024118.9×+49.6
2023Dec 29, 202369.3×+9.1
2022Dec 30, 202260.2×−174.5
2021Dec 31, 2021234.7×−190.5
2020Dec 31, 2020425.2×+423.8
2019Dec 31, 20191.4×−7.7
2018Dec 31, 20189.1×−9.0
2017Dec 29, 201718.1×+17.1
2016Dec 30, 20161.0×−10.5
2015Dec 31, 201511.5×−15.8
2014Dec 31, 201427.3×−15.2
2013Dec 31, 201342.5×–

More Traws Pharma figures

See a number that looks wrong?